Drug Shortage Report for IMITREX

Last updated on 2022-07-30 History
Report ID 161830
Drug Identification Number 02212188
Brand name IMITREX
Common or Proper name Sumatriptan succinate injection
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) SUMATRIPTAN
Strength(s) 6MG
Dosage form(s) LIQUID
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 2x0.5mL
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-06-01
Estimated end date 2022-08-05
Actual end date 2022-07-29
Shortage status Resolved
Updated date 2022-07-30
Company comments Limited supply currently available.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2022-07-30 English Compare
v9 2022-07-29 French Compare
v8 2022-07-29 English Compare
v7 2022-07-29 English Compare
v6 2022-06-29 French Compare
v5 2022-06-29 English Compare
v4 2022-06-22 French Compare
v3 2022-06-22 English Compare
v2 2022-06-03 French Compare
v1 2022-06-03 English Compare

Showing 1 to 10 of 10